Role of Antiischemic Agents in the Management of Non‐ST Elevation Acute Coronary Syndrome (NSTE‐ACS) (Q37788728)

reason for preferred rank

23 August 2017

title

Role of Antiischemic Agents in the Management of Non‐ST Elevation Acute Coronary Syndrome (NSTE‐ACS) (English)

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Role of antiischemic agents in the management of non-ST elevation acute coronary syndrome (NSTE-ACS) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20840192

12 July 2024

main subject

acute coronary syndrome

1 reference

Moutaz El-Kadri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20840192

12 July 2024

Hala Sharaf-Dabbagh

1 reference

23 August 2017

David Ramsdale

series ordinal

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20840192

12 July 2024

publication date

15 September 2010

1 reference

full work available at URL

23 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-5922.2010.00225.x

1 reference

DOI

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1755-5922.2010.00225.x

12 July 2024

1 reference

DOI

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Cardiovascular Therapeutics

12 July 2024

published in

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

e16-22

1 reference

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Evolution of the definition of myocardial infarction: what are the implications of a new universal definition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Optimal medical therapy with or without PCI for stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Progression of atheroma: a struggle between death and procreation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Innate and adaptive immunity in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Bivalirudin for patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Evolving mechanisms of action of beta blockers: focus on nebivolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Expert consensus document on beta-adrenergic receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Beta-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

beta Blockade after myocardial infarction: systematic review and meta regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Cardiac excitation-contraction coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Ca channels in cardiac myocytes: structure and function in Ca influx and intracellular Ca release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Comparison of short-term efficacy of diltiazem and propranolol in unstable angina at rest—A randomized trial in 70 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Verapamil use in patients with cardiovascular disease: an overview of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Intravenous nitroglycerine in refractory unstable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

K(ATP) channel therapeutics at the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Angina reassessed: pain or protector?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Nicorandil treatment in patients with acute myocardial infarction: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Tr

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

The cardiac pacemaker current

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)**Further information about the project, along with a complete list

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00225.X

Trimetazidine for stable angina

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003614.PUB2

Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Tissue-factor antigen and activity in human coronary atherosclerotic plaques

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Adrenergic and muscarinic receptors in the human heart

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Effect of beta blockers on expression of interleukin-6 and C-reactive protein in patients with unstable angina pectoris

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Metoprolol in acute myocardial infarction. Other clinical findings and tolerability. The MIAMI Trial Research Group

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT)

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Usefulness of esmolol in unstable angina pectoris. European Esmolol Study Group

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Usefulness of carvedilol in unstable angina pectoris

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Per

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Local control of excitation-contraction coupling in rat heart cells

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Trial of early nifedipine in acute myocardial infarction: the Trent study

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

A randomized study comparing propranolol and diltiazem in the treatment of unstable angina

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Verapamil versus propranolol for angina at rest

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

cGMP-dependent protein kinase I and smooth muscle relaxation: a tale of two isoforms

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Intravenous nitroglycerin for rest angina. Potential pathophysiologic mechanisms of action

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Intravenous nitroglycerin reduces ischaemia in unstable angina pectoris: a double-blind placebo-controlled study

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Molecular Mechanism of Action of Nicorandil

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revas

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less

12 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1755-5922.2010.00225.X

12 July 2024

Identifiers

DOI

1 reference

23 August 2017

1 reference